Inoviq (ASX:IIQ) FCF Yield % : -12.32 (As of May. 22, 2024)

View and export this data going back to 1991. Start your Free Trial

What is Inoviq FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Inoviq's Trailing 12-Month Free Cash Flow is A$-5.67 Mil, and Market Cap is A$46.01 Mil. Therefore, Inoviq's FCF Yield % for today is -12.32%.

The historical rank and industry rank for Inoviq's FCF Yield % or its related term are showing as below:

ASX:IIQ' s FCF Yield % Range Over the Past 10 Years
Min: -1879.48 Med: -626.49 Max: -4.03
Current: -12.32

During the past 13 years, the highest FCF Yield % of Inoviq was -4.03%. The lowest was -1879.48%. And the median was -626.49%.

ASX:IIQ's FCF Yield % is ranked worse than
66.38% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.445 vs ASX:IIQ: -12.32

Inoviq's FCF Margin % for the quarter that ended in Dec. 2023 was -847.47%.

Inoviq FCF Yield % Historical Data

The historical data trend for Inoviq's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq FCF Yield % Chart

Inoviq Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-126.40

-185.57

-4.02

-18.04

-9.35

Inoviq Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-6.40	-16.47	-11.29	-10.21	-5.48

Competitive Comparison of Inoviq's FCF Yield %

For the Diagnostics & Research subindustry, Inoviq's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inoviq's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Inoviq's FCF Yield % falls into.

Inoviq FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Inoviq's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-7.317	/	78.215895
	=	-9.35%

Inoviq's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.678	*	2	/	61.1924355
	=	-5.48%

Inoviq FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Inoviq FCF Yield % Related Terms

Thank you for viewing the detailed overview of Inoviq's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Inoviq (ASX:IIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168

Website

https://www.bard1.com

Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines